William Blair Issues Optimistic Outlook for IRTC Earnings

iRhythm Technologies, Inc. (NASDAQ:IRTC) – Investment analysts at William Blair upped their Q1 2025 earnings estimates for iRhythm Technologies in a research note issued to investors on Thursday, October 31st. William Blair analyst M. Kaczor now forecasts that the company will earn ($0.65) per share for the quarter, up from their previous forecast of ($0.92). The consensus estimate for iRhythm Technologies’ current full-year earnings is ($2.66) per share. William Blair also issued estimates for iRhythm Technologies’ Q2 2025 earnings at ($0.42) EPS, Q3 2025 earnings at ($0.40) EPS and Q4 2025 earnings at ($0.29) EPS.

iRhythm Technologies (NASDAQ:IRTC) last announced its earnings results on Wednesday, October 30th. The company reported ($1.26) earnings per share for the quarter, missing the consensus estimate of ($0.55) by ($0.71). iRhythm Technologies had a negative return on equity of 120.86% and a negative net margin of 26.90%. The business had revenue of $147.54 million for the quarter, compared to analyst estimates of $146.69 million. During the same quarter last year, the company posted ($0.89) EPS. iRhythm Technologies’s quarterly revenue was up 18.4% on a year-over-year basis.

Several other research analysts have also recently issued reports on the stock. Oppenheimer cut their price target on shares of iRhythm Technologies from $165.00 to $145.00 and set an “outperform” rating for the company in a report on Friday, August 2nd. Morgan Stanley cut their price target on shares of iRhythm Technologies from $135.00 to $130.00 and set an “overweight” rating for the company in a report on Monday, July 15th. The Goldman Sachs Group assumed coverage on shares of iRhythm Technologies in a report on Friday, October 4th. They issued a “neutral” rating and a $78.00 target price for the company. Canaccord Genuity Group increased their target price on shares of iRhythm Technologies from $122.00 to $137.00 and gave the company a “buy” rating in a report on Wednesday, September 25th. Finally, Robert W. Baird dropped their target price on shares of iRhythm Technologies from $100.00 to $79.00 and set an “outperform” rating for the company in a report on Friday. One equities research analyst has rated the stock with a sell rating, one has assigned a hold rating and nine have assigned a buy rating to the company. Based on data from MarketBeat.com, iRhythm Technologies has an average rating of “Moderate Buy” and a consensus price target of $108.50.

iRhythm Technologies Price Performance

Shares of IRTC opened at $81.44 on Monday. iRhythm Technologies has a fifty-two week low of $55.92 and a fifty-two week high of $124.11. The company has a market capitalization of $2.55 billion, a price-to-earnings ratio of -16.76 and a beta of 1.23. The firm has a 50-day simple moving average of $69.48 and a 200-day simple moving average of $84.64. The company has a debt-to-equity ratio of 9.00, a quick ratio of 6.76 and a current ratio of 6.27.

Hedge Funds Weigh In On iRhythm Technologies

A number of hedge funds have recently made changes to their positions in the business. Headlands Technologies LLC increased its stake in iRhythm Technologies by 10,650.0% during the 1st quarter. Headlands Technologies LLC now owns 430 shares of the company’s stock worth $50,000 after buying an additional 426 shares during the period. Nisa Investment Advisors LLC increased its stake in iRhythm Technologies by 79.6% during the 2nd quarter. Nisa Investment Advisors LLC now owns 625 shares of the company’s stock worth $67,000 after buying an additional 277 shares during the period. SG Americas Securities LLC purchased a new stake in iRhythm Technologies during the 1st quarter worth $126,000. Russell Investments Group Ltd. increased its stake in iRhythm Technologies by 79,700.0% during the 1st quarter. Russell Investments Group Ltd. now owns 1,596 shares of the company’s stock worth $185,000 after buying an additional 1,594 shares during the period. Finally, nVerses Capital LLC increased its stake in iRhythm Technologies by 400.0% during the 3rd quarter. nVerses Capital LLC now owns 2,000 shares of the company’s stock worth $148,000 after buying an additional 1,600 shares during the period.

Insider Buying and Selling at iRhythm Technologies

In other iRhythm Technologies news, CFO Brice Bobzien sold 1,372 shares of iRhythm Technologies stock in a transaction on Friday, August 9th. The shares were sold at an average price of $70.34, for a total value of $96,506.48. Following the transaction, the chief financial officer now owns 24,428 shares in the company, valued at $1,718,265.52. This trade represents a 0.00 % decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through this link. 0.68% of the stock is owned by company insiders.

About iRhythm Technologies

iRhythm Technologies, Inc, a digital healthcare company, engages in the design, development, and commercialization of device-based technology to provide ambulatory cardiac monitoring services to diagnose arrhythmias in the United States. It offers Zio services, an ambulatory monitoring solution, including long-term and short-term continuous monitoring and mobile cardiac telemetry monitoring services.